Clinical mesenchymal stromal cell products undergo functional changes in response to freezing

Cytotherapy

Volumn 17, Issue 1, 2015, Pages 38-45

  Pollock, Kathryn ^a   Sumstad, Darin ^b   Kadidlo, Diane ^b   McKenna, David H ^b   Hubel, Allison ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Freezing; Function; Mesenchymal stromal cells; Senescence; Viability

Indexed keywords

LIQUID NITROGEN;

ADULT; APOPTOSIS; ARTICLE; CELL COUNT; CELL EXPANSION; CELL VIABILITY; EX VIVO STUDY; FEMALE; FREEZING; GROWTH DISORDER; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STROMA CELL; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; THAWING; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CRYOPRESERVATION; CYTOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; APOPTOSIS; CELL COUNT; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CRYOPRESERVATION; FEMALE; FREEZING; HUMANS; MALE; MESENCHYMAL STROMAL CELLS;

EID: 84927165403     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.06.008     Document Type: Article

References (23)

1. Accessed May 20, 2013. http://www.clinicaltrials.gov.
2. Wang S., Qu X., Zhao R.C. Clinical applications of mesenchymal stem cells. JHematol Oncol 2012, 5(1):19.
3. Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal Stem/Stromal Cells: A Review of Clincal Applications and Manufacturing Practices. Transfusion. Published online October 2013,. doi:10.1111/trf.12421.
4. Hubel A. Advancing the preservation of cellular therapy products. Transfusion 2011, 51(Suppl4):82S-86.
5. Baxter M.A., Wynn R.F., Jowitt S.N., Wraith J., Fairbairn L.J., Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004, 22(5):675-682.
6. Wright L.S., Prowse K.R., Wallace K., Linskens M.H., Svendsen C.N. Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res 2006, 312(11):2107-2120.
7. Coppé J., Patil C.K., Rodier F., Krtolica A., Beausejour C.M., Parrinello S., et al. Ahuman-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One 2010, 5(2):e9188.
8. Campisi J., di Fagagna F.D. Cellular senescence: When bad things happen to good cells. Nature Reviews Molecular Cell Biology 2007, 8(9):729-740.
9. Hubel A., Darr T.B., Norman J.A. Freezing characteristics of genetically modified lymphocytes for the treatment of MPS II. Cell Transplant 1999, 8(5):521-530.
10. Hubel A., Norman J., Darr T.B. Cryobiophysical characteristics of genetically modified hematopoietic progenitor cells. Cryobiology 1999, 38(2):140-153.
11. François M., Copland I.B., Yuan S., Romieu-Mourez R., Waller E.K., Galipeau J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy 2012, 14(2):147-152.
12. Moll G., Alm J., Davies L.C., von Bahr L., Heldring N., Stenbeck-Funke L., et al. Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties. Stem Cells 2014, 32(9):2430-2442.
13. Galipeau J. The mesenchymal stromal cell dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?. Cytotherapy 2013, 15(1):2-8.
14. De Almeida R.A., Burgess D., Shema R., Motlekar N., Napper A.D., Diamond S.L., et al. Asaccharomyces cerevisiae cell-based quantitative beta-galactosidase assay compatible with robotic handling and high-throughput screening. Yeast 2008, 25(1):71-76. 10.1002/yea.1570.
15. Jag U.R., Zavadil J., Stanley F.M. Insulin Acts through FOXO3a to Activate Transcription of Plasminogen Activator Inhibitor Type 1. Mol Endocrinol 2009, 23(10):1587-1602.
16. Portalska K.J., Groen N., Krenning G., Georgi N., Mentink A., Harmsen M.C., et al. The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. Tissue Eng Part A 2013, 19(21-22):2318-2329.
17. Stolzing A., Jones E., McGonagle D., Scutt A. Age related changes in human bone marrow derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008, 129(3):163-173.
18. Sensebe L., Tarte K., Galipeau J., Krampera M., Martin I., Phinney D.G., et al. Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 2012, 10(1):9-10.
19. Bertolo A, Mehr M, Janner-Jametti T, Graumann U, Aebli N, Baur M, etal. An in vitro expansion score for tissue-engineering applications with human bone marrow derived mesenchymal stem cells. J Tissue Eng Regen Med. Prepublished on April 9, 2013 as. doi:10.1002/term.1734.
20. Wagner W., Bork S., Lepperdinger G., Joussen S., Ma N., Strunk D., et al. How to track cellular aging of mesenchymal stromal cells?. Aging 2010, 2(4):224-230.
21. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. JCell Biochem 1997 Feb, 64(2):278-294.
22. Mamidi M.K., Nathan K.G., Singh G., Thrichelvam S.T., Mohd Yusof N.A., Fakharuzi N.A., et al. Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. JCell Biochem 2012 Oct, 113(10):3153-3164.
23. Dariolli R., Bassaneze V., Nakamuta J.S., Omae S.V., Campos L.C., Krieger J.E. Porcine adipose tissue-derived mesenchymal stem cells retain their proliferative characteristics, senescence, karyotype and plasticity after long-term cryopreservation. PLoS One 2013 Jul 9, 8(7):e67939.